Recordati Industria Chimica e Farmaceutica SpA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Recordati Industria Chimica e Farmaceutica SpA with three other
pharmaceutical manufacturers in Europe:
Krka DD Novo Mesto
sales of 1.49 billion Euros [US$1.76 billion]
of which 59%
was European Union),
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
(507.79 billion Hungarian Forints [US$1.65 billion]
of which 78%
was Pharmaceutical Manufacturing and Sale), and
Swedish Orphan Biovitrum AB (publ)
based in SWEDEN
(14.25 billion Swedish Kronor [US$1.61 billion]
of which 100%
During the year ended December of 2019, sales at
Recordati Industria Chimica e Farmaceutica SpA were 1.48 billion Euro (US$1.74 billion).
increase of 9.6%
versus 2018, when the company's sales were 1.35 billion Euro.
This was the fifth consecutive year of sales increases at Recordati Industria Chimica e Farmaceutica SpA
(and since 2014, sales have increased a total of 50%).
Sales of Rare Diseases saw an increase
16.3% in 2019, from
214.83 million Euro to 249.85 million Euro.